[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fw_QfE6BW3MTJMLovuIbl88gQ0V1YlM7U_GHO72IPxd8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":7,"truncated":8,"activeTrials":9,"phase3Count":10,"totalEnrollment":11,"activePrograms":12,"nonDrugCount":13,"topConditions":14,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"St. Antonius Hospital",[4,6],"St. Antonius Hospital Gronau",98,false,24,9,131383,4,63,[15,18,20,22,24,26,28,30],{"name":16,"count":17},"Coronary Artery Disease",5,{"name":19,"count":17},"Erectile Dysfunction",{"name":21,"count":12},"Bleeding",{"name":23,"count":12},"Prostate Cancer",{"name":25,"count":12},"Quality of Life",{"name":27,"count":12},"Morbid Obesity",{"name":29,"count":12},"Aortic Valve Stenosis",{"name":31,"count":32},"Pneumonia",3,[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05926271","POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy","2026-06-15","Clopidogrel",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT04436978","What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?","2027-10-01","30-day DAPT",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06861387","Cryo Nerve Block Trial","2028-07-01","PAiN - multimodal analgesia",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,91,109,179,203,229,258,276,294,312,338,366,384,408,435,453,471,489,517,535,562,580,607,631,655,683,706,731,749,775,806,824,850,874,899,917,961,986,1013,1031,1049,1067,1089,1116,1140],{"intervention":43,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":63,"PHASE2":65,"PHASE3":67,"PHASE4":69,"NA":89},{"trials":61,"activeCount":62},[],0,{"trials":64,"activeCount":62},[],{"trials":66,"activeCount":62},[],{"trials":68,"activeCount":62},[],{"trials":70,"activeCount":58,"soonestReadout":42},[71],{"nctId":40,"briefTitle":41,"status":72,"phases":73,"primaryCompletion":42,"completion":74,"start":75,"enrollment":76,"conditions":77,"interventions":87},"RECRUITING",[54],"2027-12-01","2023-01-11",2000,[78,79,80,81,82,83,21,84,85,86,16],"Acute Coronary Syndrome","Myocardial Infarction","Atrial Fibrillation","Atrial Flutter","STEMI - ST Elevation Myocardial Infarction","NSTEMI - Non-ST Segment Elevation MI","Stroke","Stent Thrombosis","Embolism",[43,88],"Guideline-directed therapy",{"trials":90,"activeCount":62},[],{"intervention":88,"totalTrials":58,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":107},{"trials":94,"activeCount":62},[],{"trials":96,"activeCount":62},[],{"trials":98,"activeCount":62},[],{"trials":100,"activeCount":62},[],{"trials":102,"activeCount":58,"soonestReadout":42},[103],{"nctId":40,"briefTitle":41,"status":72,"phases":104,"primaryCompletion":42,"completion":74,"start":75,"enrollment":76,"conditions":105,"interventions":106},[54],[78,79,80,81,82,83,21,84,85,86,16],[43,88],{"trials":108,"activeCount":62},[],{"intervention":38,"totalTrials":17,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":125,"PHASE4":139,"NA":177},{"trials":112,"activeCount":62},[],{"trials":114,"activeCount":62},[],{"trials":116,"activeCount":58,"soonestReadout":37},[117],{"nctId":35,"briefTitle":36,"status":72,"phases":118,"primaryCompletion":37,"completion":119,"start":120,"enrollment":121,"conditions":122,"interventions":124},[52],"2027-01-15","2023-07-15",200,[78,123],"CYP2C19 Polymorphism",[38],{"trials":126,"activeCount":62},[127],{"nctId":128,"briefTitle":129,"status":130,"phases":131,"primaryCompletion":132,"completion":133,"start":134,"enrollment":135,"conditions":136,"interventions":138},"NCT05657041","Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease","UNKNOWN",[52,53],"2024-08-01","2024-11-01","2023-04-26",80,[16,137],"Platelet Reactivity",[38],{"trials":140,"activeCount":62},[141,156,167],{"nctId":142,"briefTitle":143,"status":144,"phases":145,"primaryCompletion":146,"completion":147,"start":148,"enrollment":149,"conditions":150,"interventions":154},"NCT02317198","Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly","COMPLETED",[54],"2018-11","2019-11","2013-06",1011,[151,152,153],"Non-ST-elevation Acute Coronary Syndrome","Unstable Angina","Non-ST-elevation Myocardial Infarction",[38,155],"Ticagrelor or Prasugrel",{"nctId":157,"briefTitle":158,"status":130,"phases":159,"primaryCompletion":160,"completion":161,"start":162,"enrollment":163,"conditions":164,"interventions":165},"NCT05773989","Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy",[54],"2024-12-01","2025-05-01","2024-01-23",88,[16,137],[166,38],"CYP2C19 genotype guided P2Y12 monotherapy",{"nctId":168,"briefTitle":169,"status":144,"phases":170,"primaryCompletion":171,"completion":171,"start":172,"enrollment":173,"conditions":174,"interventions":176},"NCT01012544","Platelet Reactivity in Stent Thrombosis Patients",[54],"2009-12","2009-04",187,[175],"Coronary Artery Stent Thrombosis",[38],{"trials":178,"activeCount":62},[],{"intervention":48,"totalTrials":58,"cells":180},{"EARLY_PHASE1":181,"PHASE1":183,"PHASE2":185,"PHASE3":187,"PHASE4":189,"NA":191},{"trials":182,"activeCount":62},[],{"trials":184,"activeCount":62},[],{"trials":186,"activeCount":62},[],{"trials":188,"activeCount":62},[],{"trials":190,"activeCount":62},[],{"trials":192,"activeCount":58,"soonestReadout":47},[193],{"nctId":45,"briefTitle":46,"status":72,"phases":194,"primaryCompletion":47,"completion":195,"start":196,"enrollment":197,"conditions":198,"interventions":202},[55],"2029-12-12","2026-05-01",150,[199,200,201],"Intercostal Nerve Block","Cryo Analgesia","Minimally Invasive Lung Surgery",[48],{"intervention":204,"totalTrials":58,"cells":205},"Prevnar 13",{"EARLY_PHASE1":206,"PHASE1":208,"PHASE2":210,"PHASE3":212,"PHASE4":214,"NA":227},{"trials":207,"activeCount":62},[],{"trials":209,"activeCount":62},[],{"trials":211,"activeCount":62},[],{"trials":213,"activeCount":62},[],{"trials":215,"activeCount":62},[216],{"nctId":217,"briefTitle":218,"status":144,"phases":219,"primaryCompletion":220,"completion":220,"start":221,"enrollment":222,"conditions":223,"interventions":226},"NCT02141009","Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status",[54],"2014-12","2014-04",60,[31,224,225],"Streptococcus Pneumoniae","Immune Response",[204],{"trials":228,"activeCount":62},[],{"intervention":230,"totalTrials":58,"cells":231},"Aspirin + clopidogrel",{"EARLY_PHASE1":232,"PHASE1":234,"PHASE2":236,"PHASE3":238,"PHASE4":240,"NA":256},{"trials":233,"activeCount":62},[],{"trials":235,"activeCount":62},[],{"trials":237,"activeCount":62},[],{"trials":239,"activeCount":62},[],{"trials":241,"activeCount":62},[242],{"nctId":243,"briefTitle":244,"status":144,"phases":245,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":250,"interventions":252},"NCT02247128","Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation",[54],"2020-03","2020-04","2014-01",1016,[251,79,84,21],"Aortic Valve Disease",[230,253,254,255],"Aspirin monotherapy","OAC + clopicogrel","OAC monotherapy",{"trials":257,"activeCount":62},[],{"intervention":253,"totalTrials":58,"cells":259},{"EARLY_PHASE1":260,"PHASE1":262,"PHASE2":264,"PHASE3":266,"PHASE4":268,"NA":274},{"trials":261,"activeCount":62},[],{"trials":263,"activeCount":62},[],{"trials":265,"activeCount":62},[],{"trials":267,"activeCount":62},[],{"trials":269,"activeCount":62},[270],{"nctId":243,"briefTitle":244,"status":144,"phases":271,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":272,"interventions":273},[54],[251,79,84,21],[230,253,254,255],{"trials":275,"activeCount":62},[],{"intervention":254,"totalTrials":58,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":292},{"trials":279,"activeCount":62},[],{"trials":281,"activeCount":62},[],{"trials":283,"activeCount":62},[],{"trials":285,"activeCount":62},[],{"trials":287,"activeCount":62},[288],{"nctId":243,"briefTitle":244,"status":144,"phases":289,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":290,"interventions":291},[54],[251,79,84,21],[230,253,254,255],{"trials":293,"activeCount":62},[],{"intervention":255,"totalTrials":58,"cells":295},{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":302,"PHASE4":304,"NA":310},{"trials":297,"activeCount":62},[],{"trials":299,"activeCount":62},[],{"trials":301,"activeCount":62},[],{"trials":303,"activeCount":62},[],{"trials":305,"activeCount":62},[306],{"nctId":243,"briefTitle":244,"status":144,"phases":307,"primaryCompletion":246,"completion":247,"start":248,"enrollment":249,"conditions":308,"interventions":309},[54],[251,79,84,21],[230,253,254,255],{"trials":311,"activeCount":62},[],{"intervention":313,"totalTrials":58,"cells":314},"Immunonutrition",{"EARLY_PHASE1":315,"PHASE1":317,"PHASE2":319,"PHASE3":321,"PHASE4":323,"NA":336},{"trials":316,"activeCount":62},[],{"trials":318,"activeCount":62},[],{"trials":320,"activeCount":62},[],{"trials":322,"activeCount":62},[],{"trials":324,"activeCount":62},[325],{"nctId":326,"briefTitle":327,"status":130,"phases":328,"completion":329,"start":330,"enrollment":331,"conditions":332,"interventions":335},"NCT00339053","Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair",[54],"2008-01","2004-09",142,[333,334],"Thoracic Aortic Aneurysm","Respiratory Insufficiency",[313],{"trials":337,"activeCount":62},[],{"intervention":339,"totalTrials":58,"cells":340},"sodium bicarbonate",{"EARLY_PHASE1":341,"PHASE1":343,"PHASE2":345,"PHASE3":347,"PHASE4":349,"NA":364},{"trials":342,"activeCount":62},[],{"trials":344,"activeCount":62},[],{"trials":346,"activeCount":62},[],{"trials":348,"activeCount":62},[],{"trials":350,"activeCount":62},[351],{"nctId":352,"briefTitle":353,"status":130,"phases":354,"primaryCompletion":355,"completion":356,"start":357,"enrollment":121,"conditions":358,"interventions":362},"NCT03121053","Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement",[54],"2018-12","2019-01","2016-10",[251,359,360,361],"Chronic Kidney Disease","Contrast Induced Nephropathy","Acute Kidney Injury",[339,363],"hypotone saline",{"trials":365,"activeCount":62},[],{"intervention":363,"totalTrials":58,"cells":367},{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":382},{"trials":369,"activeCount":62},[],{"trials":371,"activeCount":62},[],{"trials":373,"activeCount":62},[],{"trials":375,"activeCount":62},[],{"trials":377,"activeCount":62},[378],{"nctId":352,"briefTitle":353,"status":130,"phases":379,"primaryCompletion":355,"completion":356,"start":357,"enrollment":121,"conditions":380,"interventions":381},[54],[251,359,360,361],[339,363],{"trials":383,"activeCount":62},[],{"intervention":385,"totalTrials":58,"cells":386},"acetaminophen 2 g",{"EARLY_PHASE1":387,"PHASE1":389,"PHASE2":391,"PHASE3":393,"PHASE4":395,"NA":406},{"trials":388,"activeCount":62},[],{"trials":390,"activeCount":62},[],{"trials":392,"activeCount":62},[],{"trials":394,"activeCount":62},[],{"trials":396,"activeCount":62},[397],{"nctId":398,"briefTitle":399,"status":144,"phases":400,"primaryCompletion":401,"completion":401,"start":402,"enrollment":403,"conditions":404,"interventions":405},"NCT01764555","Pharmacokinetics of Acetaminophen in Morbidly Obese Patients",[54],"2014-03","2012-12",28,[27],[385],{"trials":407,"activeCount":62},[],{"intervention":409,"totalTrials":58,"cells":410},"trimethoprim-sulfamethoxazole",{"EARLY_PHASE1":411,"PHASE1":413,"PHASE2":415,"PHASE3":417,"PHASE4":419,"NA":433},{"trials":412,"activeCount":62},[],{"trials":414,"activeCount":62},[],{"trials":416,"activeCount":62},[],{"trials":418,"activeCount":62},[],{"trials":420,"activeCount":62},[421],{"nctId":422,"briefTitle":423,"status":144,"phases":424,"completion":425,"start":426,"enrollment":427,"conditions":428,"interventions":431},"NCT00126698","Prophylactic Antibiotics on Urethral Catheter Withdrawal",[54],"2007-04","2005-01",100,[429,430],"Urinary Tract Infection","Bacteriuria",[409,432],"ciprofloxacin",{"trials":434,"activeCount":62},[],{"intervention":432,"totalTrials":58,"cells":436},{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":443,"PHASE4":445,"NA":451},{"trials":438,"activeCount":62},[],{"trials":440,"activeCount":62},[],{"trials":442,"activeCount":62},[],{"trials":444,"activeCount":62},[],{"trials":446,"activeCount":62},[447],{"nctId":422,"briefTitle":423,"status":144,"phases":448,"completion":425,"start":426,"enrollment":427,"conditions":449,"interventions":450},[54],[429,430],[409,432],{"trials":452,"activeCount":62},[],{"intervention":155,"totalTrials":58,"cells":454},{"EARLY_PHASE1":455,"PHASE1":457,"PHASE2":459,"PHASE3":461,"PHASE4":463,"NA":469},{"trials":456,"activeCount":62},[],{"trials":458,"activeCount":62},[],{"trials":460,"activeCount":62},[],{"trials":462,"activeCount":62},[],{"trials":464,"activeCount":62},[465],{"nctId":142,"briefTitle":143,"status":144,"phases":466,"primaryCompletion":146,"completion":147,"start":148,"enrollment":149,"conditions":467,"interventions":468},[54],[151,152,153],[38,155],{"trials":470,"activeCount":62},[],{"intervention":166,"totalTrials":58,"cells":472},{"EARLY_PHASE1":473,"PHASE1":475,"PHASE2":477,"PHASE3":479,"PHASE4":481,"NA":487},{"trials":474,"activeCount":62},[],{"trials":476,"activeCount":62},[],{"trials":478,"activeCount":62},[],{"trials":480,"activeCount":62},[],{"trials":482,"activeCount":62},[483],{"nctId":157,"briefTitle":158,"status":130,"phases":484,"primaryCompletion":160,"completion":161,"start":162,"enrollment":163,"conditions":485,"interventions":486},[54],[16,137],[166,38],{"trials":488,"activeCount":62},[],{"intervention":490,"totalTrials":58,"cells":491},"Continuation of oral anticoagulants",{"EARLY_PHASE1":492,"PHASE1":494,"PHASE2":496,"PHASE3":498,"PHASE4":500,"NA":515},{"trials":493,"activeCount":62},[],{"trials":495,"activeCount":62},[],{"trials":497,"activeCount":62},[],{"trials":499,"activeCount":62},[],{"trials":501,"activeCount":62},[502],{"nctId":503,"briefTitle":504,"status":144,"phases":505,"primaryCompletion":506,"completion":507,"start":508,"enrollment":509,"conditions":510,"interventions":513},"NCT04437303","Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)",[54],"2024-03-21","2024-05-22","2020-11-25",858,[251,29,84,21,511,79,512],"Vascular Complications","Thrombosis Embolism",[490,514],"Interruption of oral anticoagulants",{"trials":516,"activeCount":62},[],{"intervention":514,"totalTrials":58,"cells":518},{"EARLY_PHASE1":519,"PHASE1":521,"PHASE2":523,"PHASE3":525,"PHASE4":527,"NA":533},{"trials":520,"activeCount":62},[],{"trials":522,"activeCount":62},[],{"trials":524,"activeCount":62},[],{"trials":526,"activeCount":62},[],{"trials":528,"activeCount":62},[529],{"nctId":503,"briefTitle":504,"status":144,"phases":530,"primaryCompletion":506,"completion":507,"start":508,"enrollment":509,"conditions":531,"interventions":532},[54],[251,29,84,21,511,79,512],[490,514],{"trials":534,"activeCount":62},[],{"intervention":536,"totalTrials":58,"cells":537},"Fentanyl",{"EARLY_PHASE1":538,"PHASE1":540,"PHASE2":542,"PHASE3":544,"PHASE4":546,"NA":560},{"trials":539,"activeCount":62},[],{"trials":541,"activeCount":62},[],{"trials":543,"activeCount":62},[],{"trials":545,"activeCount":62},[],{"trials":547,"activeCount":62},[548],{"nctId":549,"briefTitle":550,"status":144,"phases":551,"primaryCompletion":552,"completion":552,"start":553,"enrollment":554,"conditions":555,"interventions":559},"NCT02031016","Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain",[54],"2016-04","2014-02",126,[556,557,558,536],"Chronic Pain","Sternotomy","Remifentanil",[536,558,536],{"trials":561,"activeCount":62},[],{"intervention":558,"totalTrials":58,"cells":563},{"EARLY_PHASE1":564,"PHASE1":566,"PHASE2":568,"PHASE3":570,"PHASE4":572,"NA":578},{"trials":565,"activeCount":62},[],{"trials":567,"activeCount":62},[],{"trials":569,"activeCount":62},[],{"trials":571,"activeCount":62},[],{"trials":573,"activeCount":62},[574],{"nctId":549,"briefTitle":550,"status":144,"phases":575,"primaryCompletion":552,"completion":552,"start":553,"enrollment":554,"conditions":576,"interventions":577},[54],[556,557,558,536],[536,558,536],{"trials":579,"activeCount":62},[],{"intervention":581,"totalTrials":58,"cells":582},"Haemocomplettan P",{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":591,"NA":605},{"trials":584,"activeCount":62},[],{"trials":586,"activeCount":62},[],{"trials":588,"activeCount":62},[],{"trials":590,"activeCount":62},[],{"trials":592,"activeCount":62},[593],{"nctId":594,"briefTitle":595,"status":596,"phases":597,"primaryCompletion":598,"completion":598,"start":599,"enrollment":600,"conditions":601,"interventions":604},"NCT02299947","Bloodtranfusions After Aortic Surgery","TERMINATED",[54],"2018-04-26","2014-08-01",27,[602,603],"Hemorrhage","Thoracic Aneurysm",[581],{"trials":606,"activeCount":62},[],{"intervention":608,"totalTrials":58,"cells":609},"Midazolam",{"EARLY_PHASE1":610,"PHASE1":612,"PHASE2":614,"PHASE3":616,"PHASE4":618,"NA":629},{"trials":611,"activeCount":62},[],{"trials":613,"activeCount":62},[],{"trials":615,"activeCount":62},[],{"trials":617,"activeCount":62},[],{"trials":619,"activeCount":62},[620],{"nctId":621,"briefTitle":622,"status":144,"phases":623,"primaryCompletion":624,"completion":624,"start":625,"enrollment":626,"conditions":627,"interventions":628},"NCT01519726","CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug",[54],"2013-12","2011-12",20,[27],[608],{"trials":630,"activeCount":62},[],{"intervention":632,"totalTrials":58,"cells":633},"Protamine sulfate",{"EARLY_PHASE1":634,"PHASE1":636,"PHASE2":638,"PHASE3":640,"PHASE4":642,"NA":653},{"trials":635,"activeCount":62},[],{"trials":637,"activeCount":62},[],{"trials":639,"activeCount":62},[],{"trials":641,"activeCount":62},[],{"trials":643,"activeCount":62},[644],{"nctId":645,"briefTitle":646,"status":144,"phases":647,"primaryCompletion":648,"completion":648,"start":649,"enrollment":650,"conditions":651,"interventions":652},"NCT05774691","Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)",[54],"2026-01-02","2023-11-01",1000,[29],[632,632],{"trials":654,"activeCount":62},[],{"intervention":656,"totalTrials":58,"cells":657},"Atracurium, TBW",{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":681},{"trials":659,"activeCount":62},[],{"trials":661,"activeCount":62},[],{"trials":663,"activeCount":62},[],{"trials":665,"activeCount":62},[],{"trials":667,"activeCount":62},[668],{"nctId":669,"briefTitle":670,"status":144,"phases":671,"primaryCompletion":672,"completion":672,"start":673,"enrollment":626,"conditions":674,"interventions":680},"NCT01097148","Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients",[54],"2010-04","2009-11",[675,676,677,678,679],"Obese","Atracurium","Cefazolin","Morphine","Nadroparin",[656],{"trials":682,"activeCount":62},[],{"intervention":684,"totalTrials":58,"cells":685},"Diprivan",{"EARLY_PHASE1":686,"PHASE1":688,"PHASE2":690,"PHASE3":692,"PHASE4":694,"NA":704},{"trials":687,"activeCount":62},[],{"trials":689,"activeCount":62},[],{"trials":691,"activeCount":62},[],{"trials":693,"activeCount":62},[],{"trials":695,"activeCount":62},[696],{"nctId":697,"briefTitle":698,"status":144,"phases":699,"primaryCompletion":700,"completion":700,"start":701,"enrollment":626,"conditions":702,"interventions":703},"NCT00395681","Population PK\u002FPD of Propofol in the Morbidly Obese Patient",[54],"2008-09","2007-09",[27],[684],{"trials":705,"activeCount":62},[],{"intervention":707,"totalTrials":58,"cells":708},"Dexamethasone tablet 6 mg",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":727,"NA":729},{"trials":710,"activeCount":62},[],{"trials":712,"activeCount":62},[],{"trials":714,"activeCount":62},[],{"trials":716,"activeCount":62},[717],{"nctId":718,"briefTitle":719,"status":144,"phases":720,"primaryCompletion":721,"completion":721,"start":722,"enrollment":723,"conditions":724,"interventions":725},"NCT01390012","Oral Versus Intravenous Dexamethasone",[53],"2012-10","2011-08",30,[31],[707,726],"Dexamethasone injection 4 mg",{"trials":728,"activeCount":62},[],{"trials":730,"activeCount":62},[],{"intervention":726,"totalTrials":58,"cells":732},{"EARLY_PHASE1":733,"PHASE1":735,"PHASE2":737,"PHASE3":739,"PHASE4":745,"NA":747},{"trials":734,"activeCount":62},[],{"trials":736,"activeCount":62},[],{"trials":738,"activeCount":62},[],{"trials":740,"activeCount":62},[741],{"nctId":718,"briefTitle":719,"status":144,"phases":742,"primaryCompletion":721,"completion":721,"start":722,"enrollment":723,"conditions":743,"interventions":744},[53],[31],[707,726],{"trials":746,"activeCount":62},[],{"trials":748,"activeCount":62},[],{"intervention":750,"totalTrials":58,"cells":751},"Platelet Rich Plasma",{"EARLY_PHASE1":752,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":771,"NA":773},{"trials":753,"activeCount":62},[],{"trials":755,"activeCount":62},[],{"trials":757,"activeCount":62},[],{"trials":759,"activeCount":62},[760],{"nctId":761,"briefTitle":762,"status":144,"phases":763,"primaryCompletion":764,"completion":221,"start":765,"enrollment":766,"conditions":767,"interventions":770},"NCT01510639","The Influence of Growth Factors (PDGF), Applied as Autologous Thrombocyte Concentrate, on Functional Recovery",[53],"2013-07","2010-07",73,[768,769],"Rotator Cuff Rupture","Subacromial Impingement",[750],{"trials":772,"activeCount":62},[],{"trials":774,"activeCount":62},[],{"intervention":776,"totalTrials":58,"cells":777},"Small intestinal release peppermint oil",{"EARLY_PHASE1":778,"PHASE1":780,"PHASE2":782,"PHASE3":784,"PHASE4":802,"NA":804},{"trials":779,"activeCount":62},[],{"trials":781,"activeCount":62},[],{"trials":783,"activeCount":62},[],{"trials":785,"activeCount":62},[786],{"nctId":787,"briefTitle":788,"status":144,"phases":789,"primaryCompletion":790,"completion":790,"start":791,"enrollment":792,"conditions":793,"interventions":800},"NCT05799053","Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study",[53],"2024-11-30","2022-05-12",228,[794,795,796,797,798,799],"Irritable Bowel Syndrome","Functional Abdominal Pain Syndrome","Child","Adolescent","Therapeutics","Adverse Drug Event",[776,801],"Peppermint sweets",{"trials":803,"activeCount":62},[],{"trials":805,"activeCount":62},[],{"intervention":801,"totalTrials":58,"cells":807},{"EARLY_PHASE1":808,"PHASE1":810,"PHASE2":812,"PHASE3":814,"PHASE4":820,"NA":822},{"trials":809,"activeCount":62},[],{"trials":811,"activeCount":62},[],{"trials":813,"activeCount":62},[],{"trials":815,"activeCount":62},[816],{"nctId":787,"briefTitle":788,"status":144,"phases":817,"primaryCompletion":790,"completion":790,"start":791,"enrollment":792,"conditions":818,"interventions":819},[53],[794,795,796,797,798,799],[776,801],{"trials":821,"activeCount":62},[],{"trials":823,"activeCount":62},[],{"intervention":825,"totalTrials":58,"cells":826},"Metformin",{"EARLY_PHASE1":827,"PHASE1":829,"PHASE2":831,"PHASE3":833,"PHASE4":846,"NA":848},{"trials":828,"activeCount":62},[],{"trials":830,"activeCount":62},[],{"trials":832,"activeCount":62},[],{"trials":834,"activeCount":62},[835],{"nctId":836,"briefTitle":837,"status":144,"phases":838,"primaryCompletion":839,"completion":840,"start":722,"enrollment":841,"conditions":842,"interventions":845},"NCT01487993","Metformin in Obese Children and Adolescents",[53],"2015-08","2017-02-28",62,[843,844],"Obesity","Insulin Resistance",[825],{"trials":847,"activeCount":62},[],{"trials":849,"activeCount":62},[],{"intervention":851,"totalTrials":58,"cells":852},"Sugammadex",{"EARLY_PHASE1":853,"PHASE1":855,"PHASE2":857,"PHASE3":859,"PHASE4":870,"NA":872},{"trials":854,"activeCount":62},[],{"trials":856,"activeCount":62},[],{"trials":858,"activeCount":62},[],{"trials":860,"activeCount":62},[861],{"nctId":862,"briefTitle":863,"status":130,"phases":864,"primaryCompletion":221,"completion":221,"start":865,"enrollment":866,"conditions":867,"interventions":869},"NCT01855217","Pilot Study on the Pharmacodynamics of Sugammadex in Morbidly Obese Patients: Reversal of Deep Neuromuscular Blockade",[53],"2013-04",25,[868],"Neuromuscular Blockade",[851,851],{"trials":871,"activeCount":62},[],{"trials":873,"activeCount":62},[],{"intervention":875,"totalTrials":58,"cells":876},"spinal administration of articaine",{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":881,"PHASE3":883,"PHASE4":895,"NA":897},{"trials":878,"activeCount":62},[],{"trials":880,"activeCount":62},[],{"trials":882,"activeCount":62},[],{"trials":884,"activeCount":62},[885],{"nctId":886,"briefTitle":887,"status":144,"phases":888,"completion":889,"start":890,"enrollment":135,"conditions":891,"interventions":893},"NCT00247741","Spinal Anesthesia With Articaine and Lidocaine for Outpatient Surgery.",[53],"2006-05","2005-11",[892],"Spinal Anesthesia",[875,894],"spinal administration of lidocaine",{"trials":896,"activeCount":62},[],{"trials":898,"activeCount":62},[],{"intervention":894,"totalTrials":58,"cells":900},{"EARLY_PHASE1":901,"PHASE1":903,"PHASE2":905,"PHASE3":907,"PHASE4":913,"NA":915},{"trials":902,"activeCount":62},[],{"trials":904,"activeCount":62},[],{"trials":906,"activeCount":62},[],{"trials":908,"activeCount":62},[909],{"nctId":886,"briefTitle":887,"status":144,"phases":910,"completion":889,"start":890,"enrollment":135,"conditions":911,"interventions":912},[53],[892],[875,894],{"trials":914,"activeCount":62},[],{"trials":916,"activeCount":62},[],{"intervention":918,"totalTrials":32,"cells":919},"Dexamethasone",{"EARLY_PHASE1":920,"PHASE1":922,"PHASE2":924,"PHASE3":926,"PHASE4":937,"NA":949},{"trials":921,"activeCount":62},[],{"trials":923,"activeCount":62},[],{"trials":925,"activeCount":62},[],{"trials":927,"activeCount":62},[928],{"nctId":929,"briefTitle":930,"status":130,"phases":931,"primaryCompletion":932,"start":148,"enrollment":933,"conditions":934,"interventions":936},"NCT01920919","Low-dose Dexamethasone in Newly Diagnosed Pulmonary Sarcoidosis",[53],"2016-08",76,[935],"Sarcoidosis",[918],{"trials":938,"activeCount":62},[939],{"nctId":940,"briefTitle":941,"status":596,"phases":942,"primaryCompletion":943,"completion":944,"start":402,"enrollment":945,"conditions":946,"interventions":948},"NCT01743755","Santeon-CAP; Dexamethasone in Community-acquired Pneumonia",[54],"2018-07-13","2018-09-13",413,[947],"Community-acquired Pneumonia",[918],{"trials":950,"activeCount":62},[951],{"nctId":952,"briefTitle":953,"status":144,"phases":954,"primaryCompletion":955,"completion":955,"start":956,"enrollment":957,"conditions":958,"interventions":959},"NCT00471640","Dexamethasone Infusion in Community-acquired Pneumonia",[55],"2010-09","2007-11",300,[31],[960],"dexamethasone",{"intervention":962,"totalTrials":58,"cells":963},"influenza virus vaccine",{"EARLY_PHASE1":964,"PHASE1":966,"PHASE2":968,"PHASE3":970,"PHASE4":972,"NA":974},{"trials":965,"activeCount":62},[],{"trials":967,"activeCount":62},[],{"trials":969,"activeCount":62},[],{"trials":971,"activeCount":62},[],{"trials":973,"activeCount":62},[],{"trials":975,"activeCount":62},[976],{"nctId":977,"briefTitle":978,"status":144,"phases":979,"primaryCompletion":171,"completion":171,"start":980,"enrollment":981,"conditions":982,"interventions":985},"NCT01000246","Response to Influenza Virus Vaccination in Patients Immunocompromised Due to Chemotherapy",[55],"2009-10",50,[983,984],"Mamma Carcinoma","Heart Failure",[962],{"intervention":987,"totalTrials":58,"cells":988},"naropin",{"EARLY_PHASE1":989,"PHASE1":991,"PHASE2":993,"PHASE3":995,"PHASE4":997,"NA":999},{"trials":990,"activeCount":62},[],{"trials":992,"activeCount":62},[],{"trials":994,"activeCount":62},[],{"trials":996,"activeCount":62},[],{"trials":998,"activeCount":62},[],{"trials":1000,"activeCount":62},[1001],{"nctId":1002,"briefTitle":1003,"status":144,"phases":1004,"primaryCompletion":221,"completion":221,"start":1005,"enrollment":1006,"conditions":1007,"interventions":1009},"NCT01489631","Analgesia After Total Knee Replacement Surgery",[55],"2013-03",81,[1008],"Total Knee Arthroplasty",[987,1010,1011,1012],"marcaine","sufentanil","neurontin",{"intervention":1010,"totalTrials":58,"cells":1014},{"EARLY_PHASE1":1015,"PHASE1":1017,"PHASE2":1019,"PHASE3":1021,"PHASE4":1023,"NA":1025},{"trials":1016,"activeCount":62},[],{"trials":1018,"activeCount":62},[],{"trials":1020,"activeCount":62},[],{"trials":1022,"activeCount":62},[],{"trials":1024,"activeCount":62},[],{"trials":1026,"activeCount":62},[1027],{"nctId":1002,"briefTitle":1003,"status":144,"phases":1028,"primaryCompletion":221,"completion":221,"start":1005,"enrollment":1006,"conditions":1029,"interventions":1030},[55],[1008],[987,1010,1011,1012],{"intervention":1011,"totalTrials":58,"cells":1032},{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1039,"PHASE4":1041,"NA":1043},{"trials":1034,"activeCount":62},[],{"trials":1036,"activeCount":62},[],{"trials":1038,"activeCount":62},[],{"trials":1040,"activeCount":62},[],{"trials":1042,"activeCount":62},[],{"trials":1044,"activeCount":62},[1045],{"nctId":1002,"briefTitle":1003,"status":144,"phases":1046,"primaryCompletion":221,"completion":221,"start":1005,"enrollment":1006,"conditions":1047,"interventions":1048},[55],[1008],[987,1010,1011,1012],{"intervention":1012,"totalTrials":58,"cells":1050},{"EARLY_PHASE1":1051,"PHASE1":1053,"PHASE2":1055,"PHASE3":1057,"PHASE4":1059,"NA":1061},{"trials":1052,"activeCount":62},[],{"trials":1054,"activeCount":62},[],{"trials":1056,"activeCount":62},[],{"trials":1058,"activeCount":62},[],{"trials":1060,"activeCount":62},[],{"trials":1062,"activeCount":62},[1063],{"nctId":1002,"briefTitle":1003,"status":144,"phases":1064,"primaryCompletion":221,"completion":221,"start":1005,"enrollment":1006,"conditions":1065,"interventions":1066},[55],[1008],[987,1010,1011,1012],{"intervention":1068,"totalTrials":58,"cells":1069},"influenza vaccination with influenza vaccine",{"EARLY_PHASE1":1070,"PHASE1":1072,"PHASE2":1074,"PHASE3":1076,"PHASE4":1078,"NA":1080},{"trials":1071,"activeCount":62},[],{"trials":1073,"activeCount":62},[],{"trials":1075,"activeCount":62},[],{"trials":1077,"activeCount":62},[],{"trials":1079,"activeCount":62},[],{"trials":1081,"activeCount":62},[1082],{"nctId":1083,"briefTitle":1084,"status":144,"phases":1085,"primaryCompletion":148,"completion":148,"start":721,"enrollment":7,"conditions":1086,"interventions":1088},"NCT01707628","Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab",[55],[1087],"Non-Hodgkin Lymphoma (NHL)",[1068],{"intervention":1090,"totalTrials":58,"cells":1091},"Morphine & Oxycodone",{"EARLY_PHASE1":1092,"PHASE1":1094,"PHASE2":1096,"PHASE3":1098,"PHASE4":1100,"NA":1102},{"trials":1093,"activeCount":62},[],{"trials":1095,"activeCount":62},[],{"trials":1097,"activeCount":62},[],{"trials":1099,"activeCount":62},[],{"trials":1101,"activeCount":62},[],{"trials":1103,"activeCount":62},[1104],{"nctId":1105,"briefTitle":1106,"status":144,"phases":1107,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":1111,"interventions":1115},"NCT04696445","Pharmacokinetics of Morphine and Oxycodone in Frail Elderly Undergoing Cardiac Surgery",[],"2021-11-26","2020-10-01",34,[1112,1113,1114],"Opioid Use","Side Effect of Drug","Postoperative Pain",[1090],{"intervention":1117,"totalTrials":58,"cells":1118},"Levobupivacaine",{"EARLY_PHASE1":1119,"PHASE1":1121,"PHASE2":1123,"PHASE3":1125,"PHASE4":1127,"NA":1129},{"trials":1120,"activeCount":62},[],{"trials":1122,"activeCount":62},[],{"trials":1124,"activeCount":62},[],{"trials":1126,"activeCount":62},[],{"trials":1128,"activeCount":62},[],{"trials":1130,"activeCount":62},[1131],{"nctId":1132,"briefTitle":1133,"status":144,"phases":1134,"primaryCompletion":1135,"completion":1135,"start":1136,"enrollment":1110,"conditions":1137,"interventions":1139},"NCT05532618","Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery",[55],"2023-08-01","2022-08-01",[1138],"Anterior Cruciate Ligament Injuries",[1117],{"intervention":1141,"totalTrials":58,"cells":1142},"morphine",{"EARLY_PHASE1":1143,"PHASE1":1145,"PHASE2":1147,"PHASE3":1149,"PHASE4":1151,"NA":1153},{"trials":1144,"activeCount":62},[],{"trials":1146,"activeCount":62},[],{"trials":1148,"activeCount":62},[],{"trials":1150,"activeCount":62},[],{"trials":1152,"activeCount":62},[],{"trials":1154,"activeCount":62},[1155],{"nctId":1156,"briefTitle":1157,"status":144,"phases":1158,"primaryCompletion":1159,"completion":1160,"start":1161,"enrollment":197,"conditions":1162,"interventions":1164},"NCT00558090","The Optimization of Procedural Pain Control in Intensive Care Unit (ICU) Patients",[55],"2009-02","2010-02","2008-02",[1163],"Critical Illness",[1141]]